Search PDMR transactions

Notifier
Name of person with notification obligation
Keith Alexander
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Keith Alexander
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Expres2ion Biotech Holding AB
Issuer´s LEI code
549300FJK50P1ORYJC45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Warrant ExpreS2ion Biotech Holding AB TO8 SE0019925025 Exercise decrease 3,065 Quantity 1.57 SEK 13/09/2023 Outside a trading venue
Share ExpreS2ion Biotech Holding AB SE0008348262 Exercise increase 3,065 Quantity 1.57 SEK 13/09/2023 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
ExpreS2ion Biotech Holding AB TO8 SE0019925025 Exercise decrease 13/09/2023 Outside a trading venue 3,065 (Quantity) 1.57 SEK
ExpreS2ion Biotech Holding AB SE0008348262 Exercise increase 13/09/2023 Outside a trading venue 3,065 (Quantity) 1.57 SEK
<< Back